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Vibrio cholerae causes a dehydrating diarrheal illness that can be rapidly fatal in 
the absence of specific treatment. The organism is an historic scourge and, like similar 
infectious diseases, may have influenced the evolution of the human genome. We report 
here the results of the first candidate gene association study of cholera. In a family-based 
study of 76 pedigrees from Dhaka, Bangladesh, we evaluated the association between 
cholera and five candidate genes -- the cystic fibrosis transmembrane receptor; 
lactoferrin; long palate, lung and nasal epithelium clone 1 (LPLUNC1); estrogen related 
receptor alpha; and calcium activated chloride channel 1. We found a significant 
association with a marker in the promoter region of LPLUNC1 (rs11906665), a member 
of a family of evolutionarily conserved innate immunity proteins. A previous microarray-
based study of duodenal biopsies revealed significantly increased expression of 
LPLUNC1 in cholera patients compared to healthy control subjects. Our results suggest 
that variation in host innate immune responses may influence the outcome of exposure to 
V. cholerae in an endemic setting.INTRODUCTION: 
Vibrio cholerae may have played an influential role in shaping the human 
genome. Historical documents describe a dehydrating diarrheal disease consistent with 
cholera as long ago as the 7
th century, and seven pandemics with high rates of associated 
mortality have swept the globe in the last three centuries. Individuals with blood group O 
are at increased risk of severe cholera 
1, and it has been hypothesized that V. cholerae 
infection may have selected for the low prevalence of the O blood group in the Ganges 
Delta region, a historic and current epicenter of cholera. 
2 
In a family-based study of cholera in Bangladesh, we have recently demonstrated 
that individuals who are first-degree relatives of an index patient with cholera have 
significantly greater odds of being infected with V. cholerae compared to unrelated or 
less closely related contacts, when living in the same household.  This finding was 
independent of blood group phenotype in a multivariate analysis. 
3   
To begin to evaluate host genetic factors influencing susceptibility to cholera, we 
performed a family-based candidate gene association study in a cohort of individuals 
living in a cholera-endemic area of Bangladesh. We selected five candidate genes based 
on biologically plausible associations with V. cholerae infection. First, we included the 
cystic fibrosis transmembrane receptor (CFTR), since cholera has been speculated to be 
the selective pressure for the cystic fibrosis trait. 
4,5 A recently-completed microarray-
based study of duodenal biopsies of cholera patients from Bangladesh revealed increased 
expression of a number of innate immune effectors, compared to healthy control subjects. 
6 We therefore included the two most highly upregulated genes identified in this study, 
lactoferrin (LTF) and long palate, lung and nasal epithelium clone 1 (LPLUNC1), as well as a nuclear steroid receptor that regulates lactoferrin production, estrogen related 
receptor alpha (ESRRA). Lastly, we included calcium activated chloride channel 1 
(CLCA), which was detected in high levels in a proteomic evaluation of human cholera 
stools (unpublished data).  
 RESULTS: 
Characteristics of the study population 
The study population is comprised of index cases with cholera and their family 
members, all of whom share household and cooking facilities. Index cases presented to 
the Dhaka hospital of the International Centre for Diarrhoeal Disease Research in 
Bangladesh (ICDDR,B) between January 2004 and November 2005. A diagnosis of 
cholera in an index case was made by the presence of acute watery diarrhea and a stool 
culture positive for V. cholerae. Family members of the index case were defined as 
affected with cholera if they had a positive rectal swab culture for V. cholerae or 
symptoms of diarrhea during 21 days of follow up. For this analysis, the index cases and 
affected relatives were classified as affected, and all others were classified as unaffected.  
Two hundred seventy-seven individuals in 76 pedigrees were included in the 
study. In two-thirds of the pedigrees, the index case was a child. 73 pedigrees were 
nuclear families; 3 pedigrees additionally contained grandparents or grandchildren. Table 
1 shows the structure of the families included in the association study, categorized by the 
number of affected children per family.  
Table 2 shows the clinical features of the index cases as well as of the affected 
and unaffected relatives. The mean ages differed between unaffected relatives (26 + 15 
years), affected relatives (20 + 14.5 years) and index cases (18.7 + 14.5 years). The 
higher age among unaffected relatives likely reflects immunity acquired with age among 
individuals living in an endemic setting. Consistent with pre-existing immunity, there 
was a trend toward higher vibriocidal titers (representing antibodies directed at the whole 
organism) in unaffected individuals. As expected, the index cases and affected relatives were non-significantly enriched for blood group O, a previously identified risk factor for 
severe cholera.  
 
Family-based association analysis of SNPs in five candidate genes with cholera  
We evaluated SNPs in five candidate genes -- CLCA, CFTR, ESRRA, LTF and 
LPLUNC1 -- for an association with cholera in the 76 pedigrees. As outlined in Table 3, 
a total of 145 SNPs in the five genes passed quality control and were included in the 
analysis.  
We performed transmission disequilibrium testing on SNPs in each of the five 
candidate genes, using Haploview version 4.1. Supplemental Table 1 contains the results 
of TDT testing for all SNPs. Table 4 shows the SNPs that were associated with cholera 
with a nominal p value <0.05. One variant in a coding region of ESRRA, 2 variants in 
different regions of the CFTR gene, and 9 variants in LPLUNC1, primarily in the 
promoter region, were associated with cholera. Following permutation testing, only 
rs11906665, a variant in the promoter region of LPLUNC1, remained significantly 
associated with cholera. In particular, transmission of the A allele was associated with 
cholera.  
The FBAT statistical package extends the methodology of transmission 
disequilibrium testing to evaluate nuclear families that include both affected and 
unaffected offspring, and it also allows for missing parental data. Because of the varying 
affection status and family structure of these pedigrees, we performed focused association 
testing of the SNPs outlined in Table 4 using FBAT. Bi-allelic testing with an additive 
model was performed. The FBAT results, shown in Table 5, confirm the findings from TDT testing. The most highly associated SNP by FBAT was rs11906665 in LPLUNC1 (p 
= 0.0019). 
 
Haplotype-specific association analysis of LPLUNC 
  We performed a haplotype-based association analysis for SNPs in the candidate 
genes. Linkage disequilibrium (LD) between SNPs was inspected using Haploview, with 
haplotypes defined by solid spine of LD (D’ > 0.9). Common haplotypes with 
frequencies > 5% were observed in blocks for each candidate gene. After permutation 
testing was applied, no haplotype blocks, as defined by a D’ > 0.9, were significantly 
associated with cholera for any of the candidate genes (data not presented).  
Because we observed the strongest association with a variant in LPLUNC1 
(rs11906665), we additionally evaluated a 3 kb block comprised of rs17124508, 
rs11906665, rs1884884, rs17307318 and rs8115852, defined by a D’ of 1.0. Figure 1 
shows this block, which is located in the 5’ promoter region of LPLUNC1. Table 1 shows 
the haplotype frequencies and the results of transmission disequilibrium testing for this 
block. Two haplotypes that differed only by the alleles of rs11906665 were significantly 
associated with cholera after permutation testing (p = 0.001 and p = 0.012). 
 
DISCUSSION: 
  Substantial observational evidence has suggested that human genetic factors may 
influence susceptibility to V. cholerae infection. To date, no specific genetic association 
studies have been performed in cholera patients, although individuals with blood group O 
have been observed to be at higher risk of severe disease than those of other blood groups. 
1 In this study, we used a family-based cohort in an endemic area to investigate 
the association between cholera and SNPs in five candidate genes.We found a variant in 
the promoter region of LPLUNC1 to be significantly associated with cholera. This 
association was robust and was identified using two family-based tests, the TDT and 
FBAT. 
  LPLUNC1 is a member of a family of evolutionarily conserved innate immunity 
proteins that have been best studied in the palate, lung and nasal epithelium. The short 
palate, lung and nasal epithelium clone 1 protein (SPLUNC1), a close relative of 
LPLUNC1, has been shown to inhibit growth of Pseudomonas aeruginosa in vitro and to 
bind to lipopolysaccharide of the organism. 
7 A recent whole-genome microarray screen 
of gene expression in the duodenal mucosa of patients with cholera revealed LPLUNC1 
to be greater than 7-fold more highly expressed during the acute phase of infection than 
during the convalescent phase 
6; these findings were further confirmed by RT-PCR. This 
microarray study revealed a novel association between LPLUNC1 and cholera and 
generated the biological underpinnings to support the study of LPLUNC1 as a candidate 
gene for susceptibility to cholera.  
The study of the role of host genetics in susceptibility to enteric infections is in its 
infancy. Immune response genes, particularly those in the HLA locus, have been the most 
frequently identified host susceptibility factors. 
8 In a study of North American travelers 
to Mexico, a variant in exon 15 of lactoferrin was found to be associated with travelers’ 
diarrhea. 
9 Similar to LPLUNC1, lactoferrin is a component of the innate immune system 
that has antimicrobial and immunoregulatory properties. Taken together with the present 
results, this finding indicates that further studies of the relationship between variants in host innate immunity genes and the outcome of exposure to enteric organisms may be 
productive. 
  The variant in LPLUNC1 that we identified as associated with cholera, 
rs11906665, may not be the causal variant. Our haplotype analysis revealed a haplotype 
containing rs11906665 to be more significantly associated with cholera than the variant 
itself. The variant is located in the promoter region of the gene, and comparative 
sequence data indicate that this is not a conserved region of the genome across mammals 
(http://genome.ucsc.edu/). A sequence comparison with the rhesus monkey indicates that 
the G allele is the ancestral allele at this locus (http://genome.ucsc.edu/). Further 
genotyping data may help shed light on variants that are in linkage disequilibrium with 
rs11906665. 
Our study has strengths and limitations. The study population was comprised of 
nuclear families sharing water, cooking and hygiene facilities; thus, all individuals within 
the household were highly likely to have been exposed to V. cholerae along with the 
index case. By prospectively following family members for three weeks following the 
presentation of the case, we were able to obtain accurate phenotype information on these 
individuals for the current exposure. Nevertheless, individuals who were classified as 
unaffected for this analysis may have been infected with V. cholerae in the past; such 
misclassification may have limited the power of our analysis. Although we were able to 
detect evidence of an association between cholera and LPLUNC1, we cannot exclude 
additional effects of the four other genes evaluated. Validation of the association with 
LPLUNC1 should be carried out in other populations with exposure to V. cholerae, and 
further biological data delineating the mechanism of the observed association between LPLUNC1 and cholera are needed. As it is likely that more than one host genetic factor 
might contribute to susceptibility to cholera, a genome-wide search for additional 
associated loci is planned, with the aim of identifying other chromosomal regions related 
to this important global disease. 
 
MATERIALS AND METHODS: 
Study subjects: 
Samples were collected as part of a household-based prospective observational 
study aimed at identifying immunologic and host factors associated with the risk of 
cholera in an endemic setting. The study design has been described previously. 
3, 10  
Briefly, index cases presenting to the ICDDR,B hospital with severe acute watery 
diarrhea were eligible for inclusion if their stool cultures were subsequently positive for 
V. cholerae, if they were older than 6 months, and if they were without significant 
comorbid conditions. All index cases included in this analysis were infected with V. 
cholerae O1 El Tor. Upon presentation of the index case, a field team discussed 
enrollment with family members sharing a household with the index case, and consenting 
individuals were enrolled into the study immediately upon culture confirmation of the 
index case. Enrollment of family members typically occurred within 24 hours of 
presentation of the index case. All enrolled family members shared the same household 
and cooking pot as the index cases for at least the three preceding days. Blood specimens 
were collected from index cases and consenting relatives upon enrollment and over the 
course of follow-up. The field team visited households on each of the next six days, and 
again on days 14 and 21. During these visits, relatives were questioned about diarrheal symptoms, and rectal swabs were obtained for V. cholerae culture. Diarrhea was defined 
as 3 or more loose stools within a 24 hour period. Among relatives in this study, cholera 
was defined as a positive rectal swab culture for V. cholerae or symptoms of diarrhea 
during the 21 days of follow up.  
Informed consent for participation in this research was obtained from participants 
or their guardians. The human experimentation guidelines of the U.S. Department of 
Health and Human Services were followed in the conduct of this research. Approval for 
this human study was obtained from the Institutional Review Board of the Massachusetts 
General Hospital and the Research and the Ethical Review Committees of the ICDDR,B. 
 
DNA extraction: 
  Peripheral blood mononuclear cells were isolated from venous blood by gradient 
centrifugation on Ficoll-Isopaque (Pharmacia, Uppsala, Sweden). Cells were transferred 
to a cell lysis solution, and DNA was extracted according to the manufacturer’s protocol, 
including treatment with RNAse A (Gentra Puregene, Qiagen, Valencia, California). 
DNA concentration was determined by spectrophotometry. 
 
Genotyping: 
Five genes were selected for inclusion in the candidate gene association study. 
SNPs located within these genes or within 10 kilobases in either direction from the gene 
were selected using data from dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/). 
Selection focused on the inclusion of validated, coding and tagging SNPs (Tagger). 
11 
Genotyping for selected SNPs was performed using the iPlex Gold genotyping system (Sequonom, Newton, Massachusetts). Primers for each evaluated SNP were designed 
using PrimerExpress (Applied Biosystems, Foster City, California) and checked using 
Sequonom RealSNP Assay Design software (Sequonom, Newton, Massachusetts).  
Genotyping was performed on the study subjects as well as on a plate of individuals from 
the Caucasian (CEU) population of the International HapMap Project for validation. Only 
SNPs with genotyping percentages > 90% in the CEU and study populations, as well as 
minor allele frequencies > 0.01 and Hardy-Weinberg p-values > 0.01 in the study 
population, were included in the analysis. Any marker genotype inconsistencies were 
evaluated and the genotypes were zeroed for those select pedigrees.  
 
Statistical analyses: 
Quality assessment of the genotyping results was performed using Haploview 
version 4.1. 
12 Transmission disequilibrium testing was performed with Haploview 
version 4.1. Familial-based association testing was performed using the FBAT statistical 
package version 2.0.2c (http://www.biostat.harvard.edu/~fbat/default.html). Haplotypes 
were estimated using an E-M algorithm in Haploview version 4.1; haplotype blocks were 
defined using a solid spine of linkage disequilibrium (D’ > 0.9) unless otherwise 
indicated. Permutation testing was done within Haploview using 100,000 permutations 
for single markers and haplotypes; both nominal and empirical p-values are reported. 
Descriptive statistics were performed using SPSS version 10.1. Continuous variables 
were compared using one-way ANOVA and dichotomous variables were compared by 
two-sided Pearson ChiSquare. ACKNOWLEDGEMENTS: 
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 Table 1: Structure of families included in the association study, categorized by the 
number of affected children in the family * 
 
 
Number of 
affected 
children 
Number of 
families 
With 2 parents 
genotyped 
With 1 parent 
genotyped 
Number of 
healthy 
siblings 
0  12 10 2  16 
1  37 30 5  16 
2  21 14 4  21 
3  4 3 1 1 
4  2 1 0 4 
Total:  76 58 12 58 
 
 
* Only the nuclear families from 3 multigenerational pedigrees were included 
 Table 2: Clinical characteristics of cholera index cases and their affected and 
unaffected relatives * 
 
 
 Index  Cases 
(n= 71) 
Affected 
relatives  
(n= 95) 
Unaffected 
relatives  
(n =107) 
P value *** 
Age (years) **  18.7 + 14.5  20.0 + 14.5  26.0 + 15.0  0.001 
Male gender  35 (49%)  43 (45%)  53 (50%)  0.805 
Vibriocidal 
Titer, Day 2** 
304 + 732  516 + 1163  785 + 2725  0.239 
Blood Group 
O 
28 (39%)  37 (39%)  34 (32%)  0.464 
 
 
 
* Table excludes 4 relatives with unknown affected status  
** Mean + S.D. 
*** Continuous variables were compared using one-way ANOVA and dichotomous 
variables were compared by two-sided Pearson Chi Square 
  
Table 3: Candidate genes evaluated 
 
 
 
 
                 
 
Gene  Chromosome Number of SNPs that 
passed quality control  
Calcium-activated chloride channel 
(CLCA) 
1p31 47 
Cystic fibrosis transmembrane receptor 
(CFTR) 
7q31 31 
Estrogen-related receptor alpha 
(ESRRA) 
11q13 9 
Lactoferrin (LTF)  3q21  41 
Long palate, lung and nasal epithelium 
clone 1 (LPLUNC1) 
20q11 17 Table 4: Results of transmission disequilibrium testing for SNPs with nominal p<0.05 
 
 
 
* Results of 100,000 cycles of permutation testing performed in Haploview v. 4.1 
 
Gene SNP  Role  Overtransmitted 
allele 
(other allele) 
Minor 
allele 
frequency 
(minor 
allele) 
Number 
of fully 
genotyped 
trios 
Transmission: 
non-
transmissions 
to affected 
offspring 
Chi 
Square
Nominal
p value 
Permutation 
p value * 
ESRRA  rs2276014  Coding  C (T)  0.09 (T)  52  19:6  6.76  0.0093  0.0575 
CFTR  rs1800130  Coding  A (G)  0.051 (G)  53  8:1  5.444  0.0196  0.3451 
CFTR  rs713134  Promoter C (T)  0.413 (C)  52  36:19  5.255  0.0219  0.3703 
LPLUNC1  rs11906665  Promoter A (G)  0.076 (G)  51  16:1  13.235  0.0003  0.0062 
LPLUNC1  rs6057807  Promoter C (T)  0.04 (T)  56  12:2  7.143  0.0075  0.2106 
LPLUNC1  rs8118559  Promoter C (T)  0.03 (T)  53  11:2  6.231  0.0126  0.3393 
LPLUNC1  rs8118144  Promoter G (A)  0.03 (A)  57  12:3  5.4  0.0201  0.4677 
LPLUNC1  rs17124508  Promoter T (G)  0.03 (G)  57  12:3  5.4  0.0201  0.4677 
LPLUNC1  rs17307318  Promoter A (G)  0.03 (G)  57  12:3  5.4  0.0201  0.4677 
LPLUNC1  rs6057810  Promoter T (C)  0.03 (C)  56  12:3  5.4  0.0201  0.4677 
LPLUNC1 rs4398335  Intron  G  (A) 0.03  (A)  56  12:3  5.4  0.0201  0.4677 
LPLUNC1  rs8115852  Promoter G (T)  0.02 (T)  55  10:2  5.333  0.0209  0.4809 Table 5: Results of FBAT testing for selected SNPs in candidate genes 
 
 
Gene SNP  Allele  Minor 
allele 
frequency 
(minor 
allele) 
Number of 
informative 
families 
S-E(S)  Var(S)  Z’ value  P value 
ESRRA rs2276014  C  0.079  (T)  18  5.881  7.795  2.106  0.035 
CFTR rs1800130  A  0.045  (G)  7  5.5  4.25  2.668  0.0076 
CFTR rs713134  C  0.441(C)  38  11.286  16.641  2.767  0.0057 
LPLUNC1 rs11906665  A  0.055  (G)  16  7.167  5.306  3.111  0.0019 
LPLUNC1 rs6057807  C  0.029  (T)  8  5.5  3.75  2.84  0.0045 
LPLUNC1 rs8118559  C  0.025  (T)  5  5  3.5  2.673  0.0076 
LPLUNC1 rs8118144  G  0.028  (A)  8  5  4  2.5  0.012 
LPLUNC1 rs17124508  T  0.03  (G)  8  5  4  2.5  0.012 
LPLUNC1 rs17307318  A  0.03  (G)  8  5  4  2.5  0.012 
LPLUNC1 rs6057810  T  0.03  (C)  8  5  4  2.5  0.012 
LPLUNC1 rs4398335  G  0.03  (A)  8  5  4  2.5  0.012 
LPLUNC1 rs8115852  G  0.02  (T)  5  4  3  2.309  0.021 
 
  
                             
 
 
Figure 1: LPLUNC1 haplotype block. The location of each tested SNP along the 
chromosome is indicated at the top. The number in each diamond indicates the magnitude 
of LD in percent between respective pairs of SNPs. Diamonds without values represent 
perfect LD (D’ = 1.0). Dark grey diamonds represent strong evidence of LD; light grey 
diamonds are uninformative; and white diamonds represent strong evidence of 
recombination. Table 6: Results of transmission disequilibrium testing for a haplotype block in LPLUNC1  
 
 
Haplotype  Frequency  Transmission: 
non-
transmissions 
to affected 
offspring 
Chi 
Square 
Nominal 
p value 
Permutation 
p value * 
TAGAG  0.847  32.8 : 10.8  11.108  0.0009  0.001 
TGGAG  0.075  4.1 : 17.1  7.963  0.0048  0.012 
TAAAG  0.047  5.0 : 5.0  0  1  1 
GAGGT  0.026  2.8 : 11.7  5.381  0.0204  0.068 
 
* Results of 100,000 cycles of permutation testing performed in Haploview v. 4.1 